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Abstract: Gastrointestinal (GI) electrical stimulation has been shown in several studies to be a potential
treatment option for GI motility disorders. Despite the promising preliminary research progress,
however, its clinical applicability and usability are still unknown and limited due to the lack of
a miniaturized versatile implantable stimulator supporting the investigation of effective stimulation
patterns for facilitating GI dysmotility. In this paper, we present a wireless implantable GI modulation
system to fill this technology gap. The system consists of a wireless extraluminal gastrointestinal
modulation device (EGMD) performing GI electrical stimulation, and a rendezvous device (RD) and
a custom-made graphical user interface (GUI) outside the body to wirelessly power and configure
the EGMD to provide the desired stimuli for modulating GI smooth muscle activities. The system
prototype was validated in bench-top and in vivo tests. The GI modulation system demonstrated its
potential for facilitating intestinal transit in the preliminary in vivo chronic study using porcine models.
Keywords: gastrointestinal stimulation; implant; motility; neuromodulation; bioelectronics medicine;
electroceuticals
1. Introduction
The estimated annual healthcare expenditures for gastrointestinal (GI) motility disorders is
USD 29 billion, which imposes a significant burden on the U.S. healthcare system [1]. GI motility
disorder is defined as the abnormal movement behavior of the GI tract that affects the function
of mixing and propelling food. This can happen to any segment of the GI tract, including the
esophagus (e.g., dysphagia, achalasia), stomach (e.g., gastroparesis, gastroesophageal reflux disease),
and intestines (e.g., diarrhea, constipation). The pathophysiological mechanism of GI motility
disorders is not completely understood due to the complex, cooperative mechanisms between the
smooth muscle cells (SMC), interstitial cells of Cajal (ICC), enteric nervous system, central nervous
system, and hormones [2,3]. This gap of knowledge impedes the development of efficacious therapies
for improving GI motility. Although a number of pharmaceutical drugs have been developed, most of
them do not completely alleviate GI dysmotility [4]. Moreover, the use of drugs faces the challenge of
target specificity, as it is difficult to precisely control the dose of pharmacological agents.
A potential treatment alternative for GI motility disorders is GI electrical stimulation.
The fundamental principle behind this therapy is to electrically modulate myoelectric activity that
controls smooth muscle contraction/relaxation, i.e., slow waves and spikes [5]. A slow wave is
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a rhythmical electrical event originating from ICC, while a spike is the action potential that stems from
the inflow of calcium ions to the SMC. ICC and SMC are both regulated by the enteric nervous system
in the GI tract [6,7]. It is thus feasible to directly induce smooth muscle contraction through modulating
SMC or indirectly via activating the ICC/myenteric network using GI electrical stimulation. Several
studies have demonstrated the therapeutic potential of GI electrical stimulation in GI dysmotility,
including gastric electrical stimulation for pharmaceutically intractable gastroparesis [8,9], intestinal
electrical stimulation for accelerating intestinal transit [10,11], and colonic electrical stimulation for
constipation [12,13]. The potential mechanisms are either the stimulation of the SMC [8,9] or the
activation of the cholinergic or nitrergic pathways in the enteric nervous system [10–13].
Despite promising research results, the clinical applicability and usability of GI electrical
stimulation for GI motility disorders is still limited due to the lack of appropriate implantable
stimulation devices. In light of the fact that existing commercial implantable pulse generators
(e.g., deep brain stimulator, spinal cord implant, vagus nerve stimulator [14–16]) have limited
parameter programmability, the implantable GI stimulator should support a wide range of stimulation
parameters (i.e., pulse width, current intensity, frequency), especially long-pulse stimuli to activate
smooth muscle when necessary. Interestingly, even on the same GI segment, diverse stimulation
parameters have been reported for improving GI dysmotility, e.g., colonic transit could be accelerated in
rats by stimulation protocols of 4 ms, 10 mA, 40 Hz [17], and 0.3 ms, 5 mA, 10 Hz [18]. It is thus essential
to develop a device capable of versatile stimulation parameters in order to customize an optimal
stimulation strategy for each individual. This above feature is also critical, as the investigation of
an optimal stimulation protocol for effectively activating GI contraction and the sophisticated working
mechanism of the GI tract is still ongoing. Another desired feature for GI implants is the miniaturized
form factor. This would be clinically beneficial, as surgical invasiveness can be minimized during
implantation. Existing commercial GI implants are bulky and only support stimuli with a very limited
range of parameters, e.g., pulse width shorter than 1 ms [19,20]. The short pulse width limits their
usage in treating nausea and vomiting [19] or increasing the pressure of lower esophageal sphincter
for relieving gastroesophageal reflux disease [20]. Both commercial devices might not be applicable to
directly altering GI motility as most protocols for inducing GI contraction require a stimulation pulse
greater than 1 ms [8–13]. In order to fill the technology gap, a miniaturized implantable GI stimulator
supporting a wide range of stimulation parameters is needed.
We developed a wireless GI modulation system that fulfills the aforementioned needs (Figure 1).
The system consists of a wireless extraluminal gastrointestinal modulation device (EGMD) interfacing
with the gut, a custom-made graphical user interface (GUI) on a tablet for configuring the EGMD,
and a rendezvous device (RD) serving as a relay between the EGMD and the GUI. The core of the EGMD
is a system on a chip (SoC) capable of generating versatile stimulation patterns through GUI control
to modulate GI motility and wireless power and data transfer via inductive links. A heterogeneous
packaging approach integrates the SoC and printed circuit board (PCB) with a polyimide-based
electrode array, which achieves device miniaturization. The EGMD is encapsulated by biocompatible
epoxy and implanted in the abdominal wall through midline abdominal incision. The RD carried by the
subject receives user-defined commands from the GUI via WiFi link and delivers power and command
to configure the EGMD through inductive links. Design consideration and the implementation of the
EGMD were presented, and preliminary in vivo acute tests were performed [21]. Building upon our
prior work, the EGMD was advanced to a fully implantable GI modulation system; a preliminary
in vivo chronic study was conducted using porcine models to investigate its potential for accelerating
intestinal transit.
The remainder of this paper is organized as follows. Section 2 presents the microelectronic design
of the wireless implantable GI modulation system and the heterogeneous packaging technique that
achieves implant miniaturization. Section 3 presents experiment results of the GI modulation system
in bench-top and in vivo chronic tests. The conclusion is drawn in Section 4.
Micromachines 2019, 10, 525 3 of 11
Micromachines 2019, 10, x 3 of 12 
 
 
Figure 1. Illustration of wireless gastrointestinal (GI) modulation system interfacing with gut. 
2. Wireless Implantable GI Modulation System 
2.1. Microelectronic Design 
The custom-designed SoC in the wireless EGMD adapted from our prior work supports wireless 
power and data transfer, and highly programmable current-mode stimulation for activating GI 
contraction (Figure 2) [22]. The quad-voltage power converter consisting of rectifiers and voltage 
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mode stimulation. The differential phase shift keying (DPSK) receiver that is immune to the 
interference in the amplitude domain demodulates the incoming DPSK signal back to the digital 
command issued by the user. The command is then decoded by the digital controller, and the 
stimulator is set to accordingly generate the desired electrical stimuli. The highly programmable 
digital controller enables the stimulator to support intensities from 0.3 μA to 20 mA, with a pulse 
width from 10 μs to a user-defined length, and a frequency from 0.001 to 200 Hz.  
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The RD made by off-the-shelf components receives the command from the GUI on the tablet via 
WiFi and, accordingly, powers and configures the EGMD through dual-band inductive telemetries. 
Carrier frequencies of the power and data links are 2 and 22 MHz, respectively. This frequency 
separation, one decade apart, allows the use of signal filtering in the DPSK receiver to relieve power 
to data interference. In the power transmitter, a highly efficient class-E power amplifier was designed 
to drive the primary-side power coil [23]. The power amplifier is supplied by an adjustable regulator 
with voltage ranging from 2 to 10 V. This adjustability enables the power transmitter to tune the 
output-power level based on the variation of coupling coefficients between coil pairs in order to 
optimize power-transfer efficiency. On the other hand, in the data transmitter, the same architecture 
of class-E power amplifier is used, and the amplifier is driven by a noncoherent DPSK modulator 
[24]. This modulation scheme encodes the command bit in the relative phase shift between two 
consecutive symbols rather than the phase shift to a reference clock, which avoids a complicated 
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2. Wireless Implantable GI Modulation System
2.1. Microelectronic Design
The custom-designed SoC in the wireless EGMD adapted from our prior work supports wireless
power and data transfer, and highly programmable current-mode stimulation for activating GI
contraction (Figure 2) [22]. The quad-voltage power converter consisting of rectifiers and voltage
regulators receives inductive power signals from the RD and provides regulated +/–1.8 V to supply
the data receiver and the control logic, and +/–12 V to the current driver in the stimulator. The high
compliance voltage for the stimulator is critical as it allows a wide range of parameters for current-mode
stimulation. The differential phase shift keying (DPSK) receiver that is immune to the interference
in the amplitude domain demodulates the incoming DPSK signal back to the digital command
issued by the user. The command is t en decoded b the digital controller, and the stimulator is set
to accordingly generate th esired electrical stimuli. The highly programmable digital c ntroller
enables the stimulator to support intensities from 0.3 µA to 20 mA, with a pulse width from 10 µs to
a user-defined length, and a frequency from 0.001 to 200 Hz.
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The RD made by off-the-shelf components receives the command from the GUI on the tablet via
WiFi and, accordingly, powers and configures the EGMD through dual-band inductive telemetries.
Carrier frequencies of the power and data links are 2 and 22 MHz, respectively. This frequency
separation, one decade apart, allows the use of signal filtering in the DPSK receiver to relieve power to
data interference. In the ower transmitter, a highly efficient class-E power amplifier was designed to
drive the primary-side power coil [23]. Th power amplifier is supplied by an adjustable regulator
with voltage ranging from 2 to 10 V. This adju tability e ables the ow r tr smitter to tune the
output-power level based on the variation of coup ng coefficients betwe n coil pairs in order to
optimize power-transfer efficiency. On the other hand, i the data transmitter, the same rchitecture of
class-E power amplifi is used, and the amplifier is riven by a noncoherent DPSK modulator [24].
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This modulation scheme encodes the command bit in the relative phase shift between two consecutive
symbols rather than the phase shift to a reference clock, which avoids a complicated synchronization
circuit in the implant side, e.g., phase-locked loop. The scheme is realized by a XOR gate and a D
flip-flop, such that the D flip-flop toggles when the input bit is logic one and remains unchanged when
the input bit is logic zero (Figure 2). The clocks and data command required by the power and data
transmitters are generated by a microcontroller (CC3200, Texas Instruments., Dallas, TX, USA) that can
be wirelessly controlled by the tablet through WiFi. The DC–DC converter and low-dropout regulators
take input from a 3.7 V lithium ion rechargeable battery to power circuits in the RD. The wireless and
battery-power features allow the RD to be carried by freely moving subjects receiving the implant.
2.2. Heterogeneous Packaging and System Integration
The heterogeneous-packaging technique utilizes an 8 µm thick polyimide substrate to integrate
the SoC, PCB, off-chip components, and electrode array into a miniaturized EGMD (Figure 3).
The electrodes, bond pads, and the interconnections on the substrate are made of platinum/titanium
(200/10 nm thickness) fabricated by the e-beam-evaporated deposition technique [25]. All required
electrical connections for enabling system functions (e.g., the connection between electrodes and
outputs of stimulation drivers) are achieved by the patterned metal trace on the polyimide substrate,
as well as the gold bumps and ball-bonded gold wires. The gold bumps connect the polyimide
substrate with the SoC, while the connection among the substrate, SoC, and the PCB are made by the
ball-bonded gold wires. The use of a small-footprint PCB significantly facilitated the development
of the EGMD prototype. This configuration enables design debugging and the monitoring of critical
signals in the SoC by directly probing PCB pads during the system bench top test. Nevertheless, it
should be noted that the PCB is not a necessary part in the final EGMD design. Indeed, all off-chip
components can be connected to pads on the polyimide substrate via the silver conductive paste in the
absence of a PCB. After the assembly process, the EGMD is encapsulated by the epoxy (3M DP100
Plus Clear, 3M Corp., Maplewood, MN, USA). The materials interfacing with the biological tissue,
including the polyimide, platinum, and epoxy, are all biocompatible.
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Figure 3. Illustration of heterogeneous packaging for wireless extraluminal gastrointestinal modulation
device (EGMD).
Figure 4 shows the miniaturized EGMD prototype. The coaxial arrangement of power and data
coils reduces EGMD size. The separation between the coils and the PCB were suggested by the surgeon
in favor of EGMD implantation during the surgical procedure. Suturing holes were designed on the
tip of the electrod array for anchoring the array on the gut by suture. The miniaturized EGMD has
a weight of ~4.2 g and a volume of ~4.9 cm3, which is at least an order lighter and 7.7 times smaller
than existing commercialized GI implantable stimulators [19,20].
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3. Experiment Results and Discussion
The proposed wireless implantable GI modulation system was used to study its potential to
improve intestinal motility in porcine models. In order to ensure effective and safe intestinal stimulation,
the experiment protocol was designed as follows: 1) The charge injection limit and impedance of the
electrode–tissue interface were first characterized using cyclic voltammetry (CV) and two different
impedance-measurement methods. This provides a guideline for a safe stimulation protocol that
avoids any electrochemical tissue-damaging reaction in the electrode–tissue interface [26]. 2) An acute
in vivo test using the electrode array was then performed to investigate the stimulation protocol that is
also electrochemically safe for facilitating intestinal motility. 3) The wireless GI modulation system
was tested on the bench top to ensure its capability of generating the desired stimulation pattern
identified in the acute test. 4) A preliminary in vivo chronic test was finally conducted to demonstrate
the wireless GI modulation system as an effective tool for accelerating intestinal transit in porcine
models. The use of all animals was approved by the UCLA Animal Research Committee (Institutional
Review Board no. 2014-142-03E).
3.1. Electrode Characterization
The electrode–saline interface and electrode–intestinal fluid interface were both characterized for
stimulation-safety evaluation, as both extraluminal and intraluminal intestinal stimulation have been
reported as potential treatments for intestinal dysmotility [10,27]. A 0.1 M NaCl solution was used to
mimic the extraluminal environment, while intraluminal intestinal fluid was extracted from a juvenile
mini Yucatan pig. A customized electrode array that was fabricated by the same process and had
the same electrode dimension with the electrode array on the EGMD was soaked separately in both
saline and intestinal fluid. The charge injection limit, bioimpedance, and Randles cell model of both
electrode–electrolyte interfaces were characterized using CV, electrochemical impedance spectroscopy
(EIS), and the time-domain Randles cell model characterization method [28], respectively.
The measured cyclic voltammogram is shown in Figure 5, and all measured electrochemical
properties are summarized in Table 1. The electrochemical window of the electrode was [–0.9, 1 V] in
both saline and intestinal fluid environments. Charge storage capacity (CSC) of the electrode, which
defines the charge injection limit per stimulation phase, of the intestinal fluid group was 1.16 times
higher than the saline group (10.68 vs. 9.19 µC). The EIS-measured impedance of the electrode at 1 kHz
of the intestinal fluid group was 2.45 times higher than the saline (6.39 vs. 2.61 kΩ), which implies
that the maximum allowable stimulation current without exceeding the compliance voltage of the
stimulator was ~2.45 times smaller in intestinal fluid than in saline. The measured Randles cell model
of the electrode also provided the same insight, as RS was 2.26 times larger in the intestinal-fluid group
(3.69 vs. 1.63 kΩ). The product of RCT and Cdl, i.e., RC time constant, was comparable between the two
groups (29.70 vs. 29.11 µs), suggesting that the required time to discharge residual electrical charge at
the stimulation electrode was similar. According to this experiment result, extraluminal stimulation
is more beneficial compared to intraluminal, as it allows a 2.45-fold higher stimulation current, with
an acceptable penalty of 1.16-fold decrease in charge injection limit.
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Figure 5. Measured cyclic voltammogram of electrode array in saline and intestinal fluid.
Table 1. Summary of measured electrochemical properties of electrode–intestinal fluid and
electrode–saline interface.
Electrochemical Property Saline Intestinal Fluid
Cyclic voltammogram
Electrochemical window (V) [−0.9, 1] [−0.9, 1]
Charge storage capacity (µC) 9.19 10.68
Electrochemical Impedance Spectroscopy (EIS)
Magnitude@ 1 kHz (kΩ) 2.61 6.39
Phase@ 1 kHz (◦) –52.1 –53.9
Randles cell model characterization
RS (kΩ) 1.63 3.69
RCT (kΩ) 2.12 4.7
Cdl (nF) 13.73 6.32
3.2. Stimulation-Parameter Identification
In vivo acute tests using juvenile mini Yucatan pigs were conducted to investigate the effective
and safe intestinal-stimulation protocol for improving intestinal dysmotility. The animal preparation
and surgical procedures were described in our work [11]. During the experiment, a midline laparotomy
was performed, and a short segment of jejunum was identified and externalized. The jejunum was
transected, and 5 mL of ultrasound gel was placed inside (Figure 6). The segment of jejunum was then
monitored for 20 minutes, first under no stimulation, and then under electrical stimulation generated
by our SoC via the customized electrode array laid on top of the exposed segment. The gel forced back
out of the intestine via peristalsis was collected and weighed for each 20-minute time interval.
Effective stimulation parameters for increasing the rate of peristalsis were investigated in our
previous work [11]. One set of biphasic curr nt stimuli (100 Hz, 2 mA, and 2 ms) was obtained and was
able to induc both local contraction nd peristalsis (Figure 6). The result showed that in a 20-minute
time period, an average of 0.51 grams of gel were expelled without intestinal stimulation, while 1.67
grams of gel were expelled with stimulation (n = 6, p < 0.05). The potential mechanism is the activation
of ICC or the local enteric nervous system by stimulation. The identified stimulation protocol is
electrochemically safe in terms of charge injection limit. The stimulus with 2 mA intensity and 2 ms
pulse width lead to a 4 µC charge per stimulation phase, which was smaller than the charge-storage
capacity of the electrode (9.19 µC) characterized in the CV test. In addition, based on the Randles
cell model of the electrode–tissue interface characterized in the impedance measurement, it could be
estimated that the peak-to-peak voltage induced by this current stimulation pattern was around +/–7.5
V, which was within the compliance voltage of the stimulator.
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Figure 6. In vivo acute test showing that intestinal local contraction and peristalsis were initiated
through the identified stimulation protocol.
3.3. System Bench-Top Test
The wireles GI modulation device was tested on the bench top to verify its capability of generating
the desired stimulation protocol. The EGMD was powered and configured by the RD through inductive
links with a separation of 2 cm between the primary-and secondary-side coils. A GUI on an Android
tablet wirelessly controlled the RD to generate the power and data signals required by the EGMD [29].
The output of the stimulator was connected to a 1 kΩ resistor through PCB pads for current intensity
characterization. An exemplary waveform to demonstrate the operation of the wireless implantable GI
modulation system is shown in Figure 7.
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Figure 7. Stimuli of 100 Hz, 2 mA, and 2 ms were generated by the wireless GI modulation system
on the bench top. Cyan, pink, and blue traces are command sent from microco troller unit (MCU) in
the RD, command demodulated by differential phase shift keying (DPSK) receiver in EGMD, and the
induced output voltage waveform, respectively. Traces presented in time period of (a) 40 ms, (b) 10 ms,
and (c) 200 µs.
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3.4. Preliminary In Vivo Chronic Test
A preliminary in vivo chronic study was performed to validate the wireless implantable
GI modulation system and the identified stimulation protocol for accelerating intestinal motility.
Four juvenile mini Yucatan pigs underwent a laparotomy to receive EGMDs that were sterilized by
ethylene oxide. Two of the four pigs were the control group that received the EGMDs without turning
on the stimulation, while the other two received active EGMDs delivering the stimulation. The EGMD
was placed inside a pouch created in the abdominal wall, and the electrode array was sutured on
top of the intestine that was the proximal end of the jejunum identified by the ligament of Treitz
(Figure 8a) [11]. Fifteen metal beads were placed inside the intestine, about 5 cm above the segment
where the electrode array was sutured. Right after surgery, an X-ray contrast was injected into the
pig’s stomach through a gastric tube and X-ray images were acquired. The EGMD was then wirelessly
powered and configured through the RD to deliver the stimulation to the electrode that was in the
middle column and closest to the tip of the array. Each pig was trained to wear a jacket that carried the
RD before the surgery (Figure 8b). The pigs were examined three times using X-ray: right after surgery,
one day postoperative, and two days to monitor the transit of the X-ray contrast.
Micromachines 2019, 10, x 8 of 12 
 
where the electrode array was suture . Right after surgery, a  X-ray ontrast was injected into the 
pig’s stomach through a gastric tube and X-ray images were acquired. The EGMD was then wirelessly 
powered and configured through the RD to deliver the stimulation to the electrode that was in the 
middle column and closest t  the tip of the ay. Each pig was rained to we r  jack t that carried 
the RD before the surgery (Figure 8b). The pigs were examined three times using X-ray: right after 
surgery, one day postoperative, and two days to monitor the transit of the X-ray contrast.  
 
Figure 8. Experiment setup of chronic test. (a) EGMD was placed inside a pouch created in the 
abdominal wall with its electrode sutured on top of the intestine. Note that this deployment of each 
component of the EGMD helps mitigate signal loss of power and data signals due to tissue absorption, 
as separation between external and internal coils is merely abdominal-wall thickness, while the 
electrode array can be extended to access the intestine. Same deployment method is also applicable 
to future human studies to mitigate the issue of signal loss due to tissue absorption. (b) RD was carried 
by the pig. 
X-ray results showed that electrical stimulation likely facilitated intestinal transit as the contrast 
appeared in the rectum in Pig 4 on Day 1, earlier than in the other control pigs (Figure 9). Defecation 
of feces mixed with the X-ray contrast was also observed in Pig 4 on Day 1, but not clearly in other 
pigs. However, the movement of metal beads did not show coherent results in X-ray photography. 
The potential root cause is the small size and slippery surface of the metal beads that make the 
propelling of the beads inside the GI tract challenging. Although our preliminary data using EGMD 
show encouraging results, further studies involving more subjects should be conducted. 
Figure 8. Experiment setup of chronic test. (a) EGMD was placed inside a pouch created in the
abdominal wall with its electrode sutured on top of the intestine. Note that this deployment of
each component of the EGMD helps mitigate signal loss of power and data signals due to tissue
absorption, as separation between external nd internal c ils is merely abdominal-wall thickness, while
the electrode array can be extended to access the intestine. Same deployment method is also applicable
to future human studies to mitigate the issue of signal loss due to tissue absorption. (b) RD was carried
by the pig.
X-ray results showed that electrical stimulation likely facilitated intestinal transit as the contrast
appeared in the rectum in Pig 4 on Day 1, earlier than in the other control pigs (Figure 9). Defecation
of feces mixed with the X-ray contrast was also observed in Pig 4 on Day 1, but not clearly in other
pigs. However, the movement of metal beads did not show coherent results in X-ray photography.
The potential root cause is the small size and slippery surface of the metal beads that make the
propelling of the beads inside the GI tract challenging. Although our preliminary data using EGMD
sho encouraging results, further studies inv lving more subjects should be conducted.
Intestinal-tissue histology was also performed to examine for any tissue damage due to stimulation.
Three sections of jejunum were compared: normal jejunum distal to the surgical site (Section 1), jejunum
that was attached to the planar electrode array but did not receive stimulation (Section 2), and jejunum
that was attached to the planar ele trode array and received stimulation (Sect on 3) (Figure 10).
Sections 2 and 3 showed some mild inflammation and hemorrhage in the serosa and longitudinal
muscle layer, likely related to the surgical manipulation of these intestinal sections instead of the
stimulation. These changes did not appear to be clinically significant. The three different sections
appeared otherwise comparable. There was no difference in the villi or crypts seen on these sections,
and the submucosa and muscle layers also appeared similar.
Micromachines 2019, 10, 525 9 of 11
Micromachines 2019, 10, x 9 of 12 
 
 
Figure 9. Intestinal transit examined through X-ray photography. Pigs 1 and 2 are control group, 
while 3 and 4 are the experimental group. (a) Fifteen metal beads were inside the intestine, and X-ray 
contrast was in the pigs’ stomach right after the surgery. (b) On postoperative Day 1, the contrast 
appeared in the rectum in Pig 4 with electrical stimulation, while the contrast had only moved to the 
intestines in other pigs, suggesting that electrical stimulation likely facilitates intestinal transit. 
Defecation of feces was also observable in Pig 4 but not in other pigs. (c) Contrast moved to the rectum 
in all pigs on postoperative Day 2. Note that each image is combined with photos taken by the camera 
as the X-ray machine does not support an image-capture function, and its field of view is not broad 
enough to show the whole GI tract on the screen. 
Intestinal-tissue histology was also performed to examine for any tissue damage due to 
stimulation. Three sections of jejunum were compared: normal jejunum distal to the surgical site 
(Section 1), jejunum that was attached to the planar electrode array but did not receive stimulation 
(Section 2), and jejunum that was attached to the planar electrode array and received stimulation 
(Section 3) (Figure 10). Sections 2 and 3 showed some mild inflammation and hemorrhage in the 
serosa and longitudinal muscle layer, likely related to the surgical manipulation of these intestinal 
sections instead of the stimulation. These changes did not appear to be clinically significant. The three 
different sections appeared otherwise comparable. There was no difference in the villi or crypts seen 
on these sections, and the submucosa and muscle layers also appeared similar. 
  
Figure 9. Intestinal transit examined through X-ray photography. Pigs 1 and 2 are control group, while
3 and 4 are the experimental group. (a) Fifteen metal beads were inside the intestine, and X-ray contrast
was in the pigs’ stomach right after the surgery. (b) On postoperative Day 1, the contrast appeared
in the rectum in Pig 4 with electrical stimulation, while the contrast had only moved to the intestines
in other pigs, suggesting that electrical stimulation likely facilitates intestinal transit. Defecation of
feces was also observable in Pig 4 but not in other pigs. (c) Contrast moved to the rectum in all pigs on
postoperative Day 2. Note that each image is combined with photos taken by the camera as the X-ray
machine doe not support an image-capture function, and its field of vie is not br ad enough to show
the whole GI tract on the screen.
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4. Conclusions
Unlike well-established spinal cord implants and their successful commercialization, there are
very few developed GI implantable stimulators, or that have received Food and Drug Administration
(FDA) clearance. This might be attributed to the inconclusive GI working mechanism under electrical
stimulation and the challenge of developing a versatile implant system with high flexibility. To further
the advancement of treating GI dysmotility through electrical neuromodulation (i.e., electroceuticals),
we developed a wireless implantable GI modulation system. The system has demonstrated its
potential for improving GI motility. The SoC in the implantable EGMD supports wireless power
and data telemetries, and a highly programmable stimulator that can generate versatile stimuli.
The heterogeneous packaging technique achieves a miniaturized EGMD that is at least an order lighter
and 7.7 times smaller than existing commercialized GI implantable stimulators. The RD and the GUI
outside the body allow users to wirelessly power and control the EGMD to deliver a tailored stimulation
protocol for GI modulation. The system was validated on the bench top and also in preliminary in vivo
tests using porcine models. A stimulation protocol for accelerating intestinal transit was obtained and
validated in the acute test. The wireless system delivering the proposed protocol likely facilitated GI
motility in the preliminary chronic study. In addition, the protocol has shorter pulse width and smaller
intensity compared with other works for facilitating GI motility [8–10,12,13], which is beneficial for
the implantable device in terms of power consumption and stimulation safety. With the versatile
stimulation pattern feature, the wireless implantable system not only serves as a research tool for
studying an effective stimulation protocol on various GI segments, but also potential personalized
medicine that can customize optimal stimulation strategies for each individual. Its versatility and
miniaturized size also make it applicable not only to GI electrical stimulation, but also various
biomedical applications, including vagus nerve, spinal cord, and nerve regeneration stimulation.
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